Bruker (BRKR) Cash from Investing Activities (2010 - 2026)
Bruker (BRKR) posted Cash from Investing Activities of -$39.7 million for Q1 2026, up 28.47% on a QoQ basis from -$55.5 million in Q4 2025, and down 52.11% year-over-year from -$82.9 million in Q1 2025.
Bruker (BRKR) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Bruker's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$39.7 million for Q1 2026.
- Quarterly Cash from Investing Activities fell 52.11% year-over-year to -$39.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$210.1 million (up 85.8% YoY) and the FY2025 annual result came in at -$196.5 million, up 88.82% from the prior year.
- Cash from Investing Activities was -$39.7 million for Q1 2026 at Bruker, up from -$55.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $57.1 million in Q2 2022 and bottomed at -$1.3 billion in Q2 2024.
- A 5-year average of -$151.2 million and a median of -$60.6 million in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 179.97% — and 2024, when it plunged 4995.77%.
- Bruker's Cash from Investing Activities stood at -$149.3 million in 2022, then soared by 75.35% to -$36.8 million in 2023, then sank by 64.67% to -$60.6 million in 2024, then increased by 8.42% to -$55.5 million in 2025, then rose by 28.47% to -$39.7 million in 2026.
- Business Quant data shows BRKR's Cash from Investing Activities at -$39.7 million in Q1 2026, -$55.5 million in Q4 2025, and -$23.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Bruker | 9.14 Bn | 9.14 Bn | 379.80 Mn | -39.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.70 Mn |
| Mar 31, 2026 | -39.70 Mn |
| Dec 31, 2025 | -55.50 Mn |
| Dec 31, 2025 | -55.50 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Jun 30, 2025 | -91.10 Mn |
| Jun 30, 2025 | -91.10 Mn |
| Mar 31, 2025 | -26.10 Mn |
| Mar 31, 2025 | -26.10 Mn |
| Dec 31, 2024 | -60.60 Mn |
| Dec 31, 2024 | -60.60 Mn |
| Sep 30, 2024 | -67.60 Mn |
| Sep 30, 2024 | -67.60 Mn |
| Jun 30, 2024 | -1.32 Bn |
| Jun 30, 2024 | -1.32 Bn |
| Mar 31, 2024 | -304.20 Mn |
| Mar 31, 2024 | -304.20 Mn |
| Dec 31, 2023 | -36.80 Mn |
| Dec 31, 2023 | -36.80 Mn |